New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study
TRACERx researchers reported on non-small cell lung cancer features linked to disease progression, recurrence, treatment response, and more in seven new papers.
The company plans to transition its DetermaIO test from research to clinical use and to launch a new research product for immunotherapy monitoring by the end of this year.
Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles
Genomic and epigenomic data suggest it may be possible to target an FGFR fusion found in open chromatin in a subset of adenosquamous carcinoma of the pancreas tumors.
The effort will compare clinical sequencing strategies and explore best practices for educating participants and applying the results to patient care.
Lung Cancer Brain Metastasis Genomes Marked by Recurrent Amplifications, Deletions
An analysis of lung adenocarcinoma brain metastases uncovered more frequent amplifications or deletions in a handful of genomic regions, pointing to potential drivers.